This. Article ends with: > But Cantley says it may be possible to make an oral formulation that reaches high doses in the blood—which may be one way to get comp

This. Article ends with: > But Cantley says it may be possible to make an oral formulation that reaches high doses in the blood—which may be one way to get companies interested in sponsoring trials.